Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention
Genetic differences distinguish responders from nonresponders to oral insulin for T1D prevention. Genetics may enable precision medicine by identifying individuals likely to benefit from T1D-modifying therapies.
Authors
- Andrea K. Steck (ORCID: https://orcid.org/0000-0002-5931-9484)
- Taylor M. Triolo (ORCID: https://orcid.org/0000-0003-4796-6542)
- Richard A. Oram (ORCID: https://orcid.org/0000-0003-3581-8980)
- MARIA JOSE REDONDO (ORCID: https://orcid.org/0000-0001-5871-4645)
- Hemang M. Parikh (ORCID: https://orcid.org/0000-0002-9076-6709)
- Lauric Ferrat (ORCID: https://orcid.org/0000-0002-3166-9685)
- Stephen S. Rich
- Lu You
- Peter A. Gottlieb (ORCID: https://orcid.org/0000-0002-7601-8536)
- Jeffrey P. Krischer (ORCID: https://orcid.org/0000-0003-4526-888X)
- Suna Önengüt-Gümüşcü (ORCID: https://orcid.org/0000-0002-6563-8334)
- Erin L. Templeman (ORCID: https://orcid.org/0009-0007-4306-7909)
Institutions
- University of Geneva (CH)
- Baylor College of Medicine (US)
- University of Exeter (GB)
- University of South Florida (US)
- Texas Children's Hospital (US)
- University of Virginia (US)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2025-12-09
- DOI
- https://doi.org/10.2337/dc25-2006
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00